Filter
3093
Filtered Results: 3093
Text search:
trials
guidelines
Featured
Recommendations
334
New Publications
597
Language
Document type
No document type
1661
Guidelines
586
Studies & Reports
480
Manuals
170
Strategic & Response Plan
77
Fact sheets
51
Training Material
39
Situation Updates
10
Resource Platforms
8
Infographics
6
Brochures
3
App
1
Videos
1
Countries / Regions
India
166
Global
123
South Africa
83
Kenya
64
Western and Central Europe
62
Africa
45
Ethiopia
40
Nigeria
37
Uganda
37
Nepal
35
Russia
35
Tanzania
33
Sierra Leone
32
Zambia
32
Malawi
31
Liberia
31
Ghana
28
Eastern Europe
27
Brazil
27
Latin America and the Carribbean
26
Bangladesh
24
Ukraine
23
Indonesia
23
Philippines
22
Rwanda
21
Zimbabwe
21
South–East Asia Region
19
East and Southern Africa
17
Namibia
17
Asia
15
West and Central Africa
15
Mozambique
14
Cambodia
14
Germany
13
South Sudan
13
Myanmar / Burma
13
Paraguay
12
Colombia
11
Lesotho
11
Syria
11
Congo, Democratic Republic of
11
Burkina Faso
10
Guinea
10
USA
10
Middle East and North Africa
10
Eastern Europe and Central Asia
9
Thailand
8
Cameroon
8
Senegal
8
Argentina
8
Botswana
7
Eswatini/ Swaziland
7
Peru
5
Haiti
5
Western Pacific Region
5
Vietnam
5
Sudan
5
Benin
4
Chile
4
Albania
4
Guinea-Bissau
4
Jordan
4
United Kingdom
4
Spain
4
Georgia
4
Angola
4
Tajikistan
3
China
3
Laos
3
Estonia
3
North America
3
Southern Africa
3
Lebanon
3
Iraq
3
Pakistan
3
North Macedonia
2
Mexico
2
Kazakhstan
2
Iran
2
Kyrgyzstan
2
Afghanistan
2
Burundi
2
Morocco
2
Venezuela
2
Hungary
2
Jamaica
2
Portugal
2
Bolivia
2
Sri Lanka
2
Yemen
2
Mali
2
Somalia
2
Timor Leste/ East Timor
1
El Salvador
1
Turkey
1
Gambia
1
Singapore
1
Qatar
1
Bulgaria
1
Armenia
1
Saudi Arabia
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Egypt
1
Greece
1
Central African Republic
1
Poland
1
Honduras
1
Chad
1
Bhutan
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
862
Clinical Guidelines
409
Public Health
206
Women & Child Health
194
Key Resources
91
Capacity Building
37
Pharmacy & Technologies
36
Toolboxes
Mental Health
366
HIV
358
TB
276
COVID-19
270
NTDs
126
NCDs
110
Caregiver
88
AMR
80
Rapid Response
65
Ebola & Marburg
60
Pharmacy
60
Disability
59
Malaria
56
Planetary Health
50
Conflict
37
Refugee
29
Global Health Education
24
Natural Hazards
16
Polio
15
Cholera
13
Health Financing Toolbox
13
Zika
9
Specific Hazards
8
Social Ethics
7
Typhoon
1
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
WHO/ESCAP Training Manual on Disability Statistics | This training manual intends to enhance the understanding of the ICF-based approach to disability measurement. It provides an overview of the ICF framework as well as guidelines on how to operationalize the underlying concepts of functioning and ...
Background
Noncommunicable diseases are major contributors to morbidity and mortality worldwide. Modifying the risk factors for these conditions, such as physical inactivity, is thus essential. Addressing the context or circumstances in which physical activity occurs may promote physical activity a...
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline d...
2nd edition. This new edition provides policy-makers, programme managers and health-service providers with the latest evidence-based guidance on clinical care. It includes information on how to establish and strengthen services, and outlines a human-rights-based approach to laws and policies on safe...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
This special issue on Newborn Health in Global Health Action is being launched to share the experience of how to scale up a cost-effective package of newborn care that involves families, community health workers and health facilities. The results of this community randomized trial, the Uganda Newbor...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
The report discusses the epidemiological and social aspects of ageing, health and functional changes experienced with ageing, the impact of physical activity, assessment of the nutritional status of older persons, and nutritional guidelines for healthy ageing.
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and...
The aim of this protocol is to support the conduct of entomological comparative efficacy assessments for vector control products and the associated non-inferiority analysis. This evidence is used to inform discussions within the guidelines development context as to whether a new vector control prod...
